Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F24%3A00013715" target="_blank" >RIV/00023736:_____/24:00013715 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/24:00137181 RIV/61988987:17110/24:A25039NB RIV/00216208:11110/24:10484199 RIV/00216208:11120/24:43927517 and 8 more
Result on the web
<a href="https://doi.org/10.1002/cam4.70138" target="_blank" >https://doi.org/10.1002/cam4.70138</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/cam4.70138" target="_blank" >10.1002/cam4.70138</a>
Alternative languages
Result language
angličtina
Original language name
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration
Original language description
The aim of this study was to analyse the outcomes of patients with large B-cell lymphoma (LBCL) treated with chimeric antigen receptor T-cell therapy (CAR-Tx), with a focus on outcomes after CAR T-cell failure, and to define the risk factors for rapid progression and further treatment. Our findings allow better stratification of CAR-Tx candidates and stress the need for a proactive approach (earlier restaging, intervention after partial remission achievement).
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
<a href="/en/project/NU21-03-00411" target="_blank" >NU21-03-00411: Early identification of prognostic factors connected with worse outcome of Non-Hodgkin’s Lymphoma</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer medicine
ISSN
2045-7634
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
17
Country of publishing house
US - UNITED STATES
Number of pages
15
Pages from-to
"art.no. e70138"
UT code for WoS article
001308743500001
EID of the result in the Scopus database
2-s2.0-85203439909